Author: Hamilton John D. Freeman Michael B. Reinert Kevin H.
Publisher: Taylor & Francis Ltd
ISSN: 1087-2620
Source: Journal of Toxicology and Environmental Health, Vol.49, Iss.1, 1996-09, pp. : 67-82
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis
By Gupta A.K.
Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. :
A Risk-Benefit Assessment of Drugs Used for Neonatal Chronic Lung Disease
Drug Safety, Vol. 22, Iss. 5, 2000-05 ,pp. :
A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke
By MacWalter R.S. Shirley C.P.
Drug Safety, Vol. 25, Iss. 13, 2002-01 ,pp. :